Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Isnard, Christophe
229  Ergebnisse:
Personensuche X
?
1

PIK3CA inhibition in models of proliferative glomerulonephr..:

Yamaguchi, Junna ; Isnard, Pierre ; Robil, Noémie...
Journal of Clinical Investigation.  , 2024
Link: https://doi.org/10.1172/..
 
?
2

Occurrence of in vivo carbapenem-resistant Campylobacter co..:

Maurille, Charles ; Guérin, François ; Jehanne, Quentin...
Clinical Microbiology and Infection.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Rationale and design of the PACIFIC-PRESERVED (PhenomApping..:

Hulot, Jean-Sébastien ; Janiak, Philip ; Boutinaud, Philippe...
Archives of Cardiovascular Diseases.  117 (2024)  5 - p. 332-342 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès B. ; Bernabeu, Sandrine ; Emeraud, Cécile...
Journal of Global Antimicrobial Resistance.  32 (2023)  - p. 78-84 , 2023
Link: https://doi.org/10.1016/..
 
?
5

A specific molecular signature in SARS-CoV-2–infected kidne..:

Isnard, Pierre ; Vergnaud, Paul ; Garbay, Serge...
JCI Insight.  8 (2023)  5 - p. , 2023
Link: https://doi.org/10.1172/..
 
?
6

Interest in the combination of antimicrobial therapy for or..:

Maurille, Charles ; Michon, Jocelyn ; Isnard, Christophe...
Archives of Orthopaedic and Trauma Surgery.  143 (2023)  9 - p. 5515-5526 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Feasibility and accuracy of linking a heart failure registr..:

Logeart, Damien ; Damy, Thibaud ; Doublet, Maxime...
Archives of Cardiovascular Diseases.  116 (2023)  1 - p. 18-24 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
?
9

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
?
10

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
?
11

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
?
12

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
?
13

A specific molecular signature in SARS-CoV-2–infected kidne..:

Isnard, Pierre ; Vergnaud, Paul ; Garbay, Serge...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077488/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
?
15

Evaluation of ceftolozane-tazobactam susceptibility on a Fr..:

Jousset, Agnès ; Bernabeu, Sandrine ; Emeraud, Cécile...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jgar.2023.01.003.  , 2023
Link: https://inserm.hal.scien..
 
1-15